These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 10572605)
1. Factors associated with tumor volume and primary metastases in Ewing tumors: results from the (EI)CESS studies. Hense HW; Ahrens S; Paulussen M; Lehnert M; Jürgens H Ann Oncol; 1999 Sep; 10(9):1073-7. PubMed ID: 10572605 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study. Ahrens S; Hoffmann C; Jabar S; Braun-Munzinger G; Paulussen M; Dunst J; Rübe C; Winkelmann W; Heinecke A; Göbel U; Winkler K; Harms D; Treuner J; Jürgens H Med Pediatr Oncol; 1999 Mar; 32(3):186-95. PubMed ID: 10064186 [TBL] [Abstract][Full Text] [Related]
3. [Descriptive epidemiology of Ewing's tumor--analysis of German patients from (EI)CESS 1980-1997]. Hense HW; Ahrens S; Paulussen M; Lehnert M; Jürgens H Klin Padiatr; 1999; 211(4):271-5. PubMed ID: 10472561 [TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of tumor perfusion in MR-imaging studies in Ewing tumors. Dunst J; Ahrens S; Paulussen M; Burdach S; Jürgens H Strahlenther Onkol; 2001 Mar; 177(3):153-9. PubMed ID: 11285773 [TBL] [Abstract][Full Text] [Related]
5. Age dependency of primary tumor sites and metastases in patients with Ewing sarcoma. Worch J; Ranft A; DuBois SG; Paulussen M; Juergens H; Dirksen U Pediatr Blood Cancer; 2018 Sep; 65(9):e27251. PubMed ID: 29856530 [TBL] [Abstract][Full Text] [Related]
6. Current concepts in the treatment of Ewing's sarcoma. Weber KL Expert Rev Anticancer Ther; 2002 Dec; 2(6):687-94. PubMed ID: 12503215 [TBL] [Abstract][Full Text] [Related]
7. Metastatic Ewing sarcoma/PNET of bone at diagnosis: prognostic factors--a report from Saudi Arabia. Jenkin RD; Al-Fawaz I; Al-Shabanah MO; Allam A; Ayas M; Memon M; Rifai S; Schultz HP Med Pediatr Oncol; 2001 Oct; 37(4):383-9. PubMed ID: 11568903 [TBL] [Abstract][Full Text] [Related]
8. Ewing sarcoma of the pelvis: Clinical features and overall survival Brown JM; Rakoczy K; Tokson JH; Jones KB; Groundland JS Cancer Treat Res Commun; 2022; 33():100634. PubMed ID: 36126512 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow. Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822 [TBL] [Abstract][Full Text] [Related]
11. Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. Paulussen M; Ahrens S; Burdach S; Craft A; Dockhorn-Dworniczak B; Dunst J; Fröhlich B; Winkelmann W; Zoubek A; Jürgens H Ann Oncol; 1998 Mar; 9(3):275-81. PubMed ID: 9602261 [TBL] [Abstract][Full Text] [Related]
12. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003. Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634 [TBL] [Abstract][Full Text] [Related]
13. Imaging Features of Primary Tumors and Metastatic Patterns of the Extraskeletal Ewing Sarcoma Family of Tumors in Adults: A 17-Year Experience at a Single Institution. Huh J; Kim KW; Park SJ; Kim HJ; Lee JS; Ha HK; Tirumani SH; Ramaiya NH Korean J Radiol; 2015; 16(4):783-90. PubMed ID: 26175577 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on Inagaki C; Shimoi T; Sumiyoshi Okuma H; Kawachi A; Sudo K; Shimomura A; Noguchi E; Kodaira M; Yunokawa M; Yonemori K; Shimizu C; Arakawa A; Ogawa C; Yoshida A; Fujiwara Y; Tamura K Med Oncol; 2019 May; 36(7):58. PubMed ID: 31104192 [TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
17. Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours. Györke T; Zajic T; Lange A; Schäfer O; Moser E; Makó E; Brink I Nucl Med Commun; 2006 Jan; 27(1):17-24. PubMed ID: 16340719 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for detectable metastatic disease at presentation in Ewing sarcoma - An analysis of the SEER registry. Ramkumar DB; Ramkumar N; Miller BJ; Henderson ER Cancer Epidemiol; 2018 Dec; 57():134-139. PubMed ID: 30412903 [TBL] [Abstract][Full Text] [Related]
19. Whole-body MRI vs bone scintigraphy in the staging of Ewing sarcoma of bone: a 12-year single-institution review. Kalus S; Saifuddin A Eur Radiol; 2019 Oct; 29(10):5700-5708. PubMed ID: 30915559 [TBL] [Abstract][Full Text] [Related]
20. Time to diagnosis of Ewing tumors in children and adolescents is not associated with metastasis or survival: a prospective multicenter study of 436 patients. Brasme JF; Chalumeau M; Oberlin O; Valteau-Couanet D; Gaspar N J Clin Oncol; 2014 Jun; 32(18):1935-40. PubMed ID: 24841977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]